Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07048886
PHASE4
Rocklatan Adds Pressure Reduction After MIGS (Minimally Invasive Glaucoma Surgery)
Sponsor: Center for Sight Las Vegas
View on ClinicalTrials.gov
Summary
The primary objective of this study is to determine if the addition of Rocklatan post-Hydrus will provide additional intraocular pressure lowering.
Key Details
Gender
All
Age Range
40 Years - Any
Study Type
INTERVENTIONAL
Enrollment
68
Start Date
2025-07-15
Completion Date
2026-12-31
Last Updated
2025-07-03
Healthy Volunteers
No
Conditions
Interventions
DRUG
Rocklatan (netarsudil 0.02% and latanoprost 0.005%)
Additional intraocular eye pressure lowering post-Hydrus
DRUG
Systane
Placebo Comparator (artificial tears)
Locations (1)
Center for Sight
Las Vegas, Nevada, United States